|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/00 | (2006.01) |
| A61K 31/00 | (2013.01) | ||
| A61K 31/7048 | (2006.01) | ||
| A61K 31/7048 | (2013.01) | ||
| A61P 21/00 | (2006.01) | ||
| A61P 21/00 | (2018.01) | ||
| A61P 3/06 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 3/10 | (2018.01) |
| (11) | Number of the document | 3362055 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16781135.5 |
| Date of filing the European patent application | 2016-10-13 | |
| (97) | Date of publication of the European application | 2018-08-22 |
| (45) | Date of publication and mention of the grant of the patent | 2023-01-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2016/074601 |
| Date | 2016-10-13 |
| (87) | Number | WO 2017/064193 |
| Date | 2017-04-20 |
| (30) | Number | Date | Country code |
| 201562242030 P | 2015-10-15 | US | |
| 201662347747 P | 2016-06-09 | US |
| (72) |
MAYOUX, Eric Williams , DE
|
| (73) |
Boehringer Ingelheim International GmbH ,
Binger Strasse 173, 55216 Ingelheim am Rhein,
DE
|
| (54) | SGLT-2 INHIBITOR FOR USE IN THE TREATMENT OF A METABOLIC MYOPATHY |
| SGLT-2 INHIBITOR FOR USE IN THE TREATMENT OF A METABOLIC MYOPATHY |